Skip to content

Herbal formulation for immunity boosting during pandemic

Open label single center prospective study to assess the efficacy of herbal formulation for immunity boosting during COVID-19 pandemic - AVHF

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026528
Enrollment
500
Registered
2020-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Herbal Formulation: Guduchi Ashwagandha Tulasi Haridra Sunthi Maricha Pimpali Twak Kirattikta Bhumyalaki Control Intervention1: Not Applicable: Not Applicable

Sponsors

Aparna Abhay Raut
Lead Sponsor
Shree Saptashrungi Ayurved Mahavidyalaya and Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subject willing to give voluntary informed consent 2. Irrespective Sex 3. Healthy Volunteers 4. Health Workers 5. Front line workers during pandemic 6. Subject having travelling history 7. Subject willing to follow the procedure as per the study protocol

Exclusion criteria

Exclusion criteria: 1. COVID 19 positive patient 2. Fever 3. Hypersensitivity or idiosyncratic reaction to any drugs or herbal products 4. History of allergic condition 5. History of psychiatric disorder 6. Presence of abnormal laboratory report 7. Known subject of malignancy 8. Subject of participating in another clinical study

Design outcomes

Primary

MeasureTime frame
1-Number of individuals developing symptoms 2-Number of individuals turning COVID 19 test positiveTimepoint: 0-enrollment of patient for intervention(baseline) Follow up after 2 weeks. Outcome will be assessed 1-Baseline- 2nd-after 4 week 3rd - after 6 week 4th-after 8 week 5th -after 10 week 6th- after 12 week

Secondary

MeasureTime frame
1 Number of individuals developing symptoms. 2 Number of individuals turning COVID 19 test positive. 3 Adverse events. 4 Improvement in immune status using immune status qustionnaire.Timepoint: secondary outcome will be assessed after 6 month from baseline.

Countries

India

Contacts

Public ContactShailaja Prakash Chondikar

Shree Saptashrungi Ayurved Mahavidyalaya and Hospital

shailajachondikar@gmail.com9730866968

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026